SFOSF SHANGHAI FOSUN PHARMACEUTICAL GROUP

Watchlist

1.699
0.0000.00%

15min DelayTrading Jan 3 16:00 ET

4.54BMarket Cap15.73P/E (TTM)

SHANGHAI FOSUN PHARMACEUTICAL GROUP Key Stats

According to the latest financial report of SHANGHAI FOSUN PHARMACEUTICAL GROUP, the latest earnings per share (TTM) for the company is 0.29. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Quarterly

FCF

Interested in knowing about SHANGHAI FOSUN PHARMACEUTICAL GROUP's free cash flow? The latest report shows it as 146.04M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: CNY

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of SHANGHAI FOSUN PHARMACEUTICAL GROUP shows that the company's current ratio is 0.92, indicating healthy liquidity.

Currency: CNY

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of SHANGHAI FOSUN PHARMACEUTICAL GROUP, the quick ratio is 0.68, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Quarterly

ROE

Want to learn more about the financial health of SHANGHAI FOSUN PHARMACEUTICAL GROUP? The latest ROE figure is 1.67%, indicating that the company has stable profitability.

Currency: CNY

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of SHANGHAI FOSUN PHARMACEUTICAL GROUP, the total asset return on investment (ROA) is 0.68%.

Currency: CNY

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check SHANGHAI FOSUN PHARMACEUTICAL GROUP's latest financial report to see how their gross margin is doing - currently at 48.07%.

Currency: CNY

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of SHANGHAI FOSUN PHARMACEUTICAL GROUP, the net profit margin is 9.27%, which is a good sign for its profitability.

Currency: CNY

Quarterly

Trending Stocks